Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bowser

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Muscle & Nerve|September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosisJames D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Communications Biology|January 22, 2020
CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individualYeomin Yun, Sung-Ah Hong, Ka-Kyung Kim, et al.
Nature Medicine|December 24, 2021
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Michael P Moazami, Huiya Yang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 25, 2023
ALSUntangled # 69: astaxanthinTimothy Fullam, Carmel Armon, Paul Barkhaus, et al.
Neurobiology of Disease|December 28, 2020
The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron diseaseNadine Bakkar, Alexander Starr, Benjamin E Rabichow, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosisDaisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 20, 2020
A multi-center study of neurofilament assay reliability and inter-laboratory variabilityElizabeth Gray, Patrick Oeckl, Maria D M Amador, et al.
Muscle & Nerve|November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosisSalman Bhai, Todd Levine, Dan Moore, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 22, 2024
ALSUntangled #77: PsilocybinBhavya Bakshi, Sandeep Yerraguntla, Carmel Armon, et al.
Scientific Reports|November 7, 2024
Author Correction: Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocolsRuth Luthi-Carter, Sara Cappelli, Morgan Le Roux-Bourdieu, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Muscle & Nerve|September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosisJames D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Communications Biology|January 22, 2020
CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individualYeomin Yun, Sung-Ah Hong, Ka-Kyung Kim, et al.
Nature Medicine|December 24, 2021
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Michael P Moazami, Huiya Yang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 25, 2023
ALSUntangled # 69: astaxanthinTimothy Fullam, Carmel Armon, Paul Barkhaus, et al.
Neurobiology of Disease|December 28, 2020
The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron diseaseNadine Bakkar, Alexander Starr, Benjamin E Rabichow, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosisDaisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 20, 2020
A multi-center study of neurofilament assay reliability and inter-laboratory variabilityElizabeth Gray, Patrick Oeckl, Maria D M Amador, et al.
Muscle & Nerve|November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosisSalman Bhai, Todd Levine, Dan Moore, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 22, 2024
ALSUntangled #77: PsilocybinBhavya Bakshi, Sandeep Yerraguntla, Carmel Armon, et al.
Scientific Reports|November 7, 2024
Author Correction: Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocolsRuth Luthi-Carter, Sara Cappelli, Morgan Le Roux-Bourdieu, et al.
Pageof 15